Christopher Timmermann (PhD) obtained a BSc in Psychology in Santiago, Chile and an MSc in Cognitive Neuroscience at the University of Bologna in Italy. He is currently a post-doc at Imperial College London at the Centre for Psychedelic Research, where he leads the DMT Research Group, specialized in the potent psychedelics N,N-DMT and 5-MeO-DMT and their effects on the human brain and consciousness. His empirical and theoretical work focuses on the neuroscience, psychiatry, psychology, pharmacology, beliefs and ethics of psychedelics, their relationship to consciousness and applications in mental health. His work has been covered by the BBC, CBC, Wired, The Times, and New Scientist. |